78 related articles for article (PubMed ID: 25193356)
1. Detection of dicentric chromosome (9;20) in paediatric B-cell acute lymphoblastic leukaemia: prognostic significance.
Letouzey M; Penther D; Roche-Lestienne C; Nelken B; Devoldère C; Vannier JP; Schneider P
Ann Hematol; 2015 Feb; 94(2):187-93. PubMed ID: 25193356
[TBL] [Abstract][Full Text] [Related]
2. An acquired stable variant of a dicentric dic(9;20) and complex karyotype in a Syrian childhood B-acute lymphoblastic leukemia case.
Wafa A; Jarjour RA; Aljapawe A; ALmedania S; Liehr T; Melo JB; Carreira IM; Othman MAK; Al-Achkar W
Mol Cytogenet; 2020; 13():29. PubMed ID: 32670411
[TBL] [Abstract][Full Text] [Related]
3. Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive KMT2A fluorescence in situ hybridization result.
Nunn J; Adayapalam N; Riyat S; Seymour L; Williams B; Rehn J; White D; Moore AS; Tsuchiya K
Cancer Genet; 2023 Nov; 278-279():80-83. PubMed ID: 37742392
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.
Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M
Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457
[TBL] [Abstract][Full Text] [Related]
5. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Irving JA; Enshaei A; Parker CA; Sutton R; Kuiper RP; Erhorn A; Minto L; Venn NC; Law T; Yu J; Schwab C; Davies R; Matheson E; Davies A; Sonneveld E; den Boer ML; Love SB; Harrison CJ; Hoogerbrugge PM; Revesz T; Saha V; Moorman AV
Blood; 2016 Aug; 128(7):911-22. PubMed ID: 27229005
[TBL] [Abstract][Full Text] [Related]
6. dic(7;9)(p11-13;p11).
Underdown MJ; Russell TB; Pettenati MJ; Kram DE
Atlas Genet Cytogenet Oncol Haematol; 2006; 10(2):110-111. PubMed ID: 34531928
[TBL] [Abstract][Full Text] [Related]
7. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.
Clappier E; Grardel N; Bakkus M; Rapion J; De Moerloose B; Kastner P; Caye A; Vivent J; Costa V; Ferster A; Lutz P; Mazingue F; Millot F; Plantaz D; Plat G; Plouvier E; Poirée M; Sirvent N; Uyttebroeck A; Yakouben K; Girard S; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2015 Nov; 29(11):2154-61. PubMed ID: 26050650
[TBL] [Abstract][Full Text] [Related]
8. Blinatumomab: A First-in-Class Bispecific T-Cell Engager for Precursor B-Cell Acute Lymphoblastic Leukemia.
Buie LW; Pecoraro JJ; Horvat TZ; Daley RJ
Ann Pharmacother; 2015 Sep; 49(9):1057-67. PubMed ID: 26041811
[TBL] [Abstract][Full Text] [Related]
9. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
10. Paving the road ahead for CD19 CAR T-cell therapy.
Nellan A; Lee DW
Curr Opin Hematol; 2015 Nov; 22(6):516-20. PubMed ID: 26335422
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases.
Chopra A; Soni S; Verma D; Kumar D; Dwivedi R; Vishwanathan A; Vishwakama G; Bakhshi S; Seth R; Gogia A; Kumar L; Kumar R
Asia Pac J Clin Oncol; 2015 Dec; 11(4):293-8. PubMed ID: 26264145
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.
Borowitz MJ; Wood BL; Devidas M; Loh ML; Raetz EA; Salzer WL; Nachman JB; Carroll AJ; Heerema NA; Gastier-Foster JM; Willman CL; Dai Y; Winick NJ; Hunger SP; Carroll WL; Larsen E
Blood; 2015 Aug; 126(8):964-71. PubMed ID: 26124497
[TBL] [Abstract][Full Text] [Related]
13. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
14. Clinical overview of anti-CD19 BiTE(®) and ex vivo data from anti-CD33 BiTE(®) as examples for retargeting T cells in hematologic malignancies.
Zugmaier G; Klinger M; Schmidt M; Subklewe M
Mol Immunol; 2015 Oct; 67(2 Pt A):58-66. PubMed ID: 25883042
[TBL] [Abstract][Full Text] [Related]
15. IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients.
Pulsipher MA; Carlson C; Langholz B; Wall DA; Schultz KR; Bunin N; Kirsch I; Gastier-Foster JM; Borowitz M; Desmarais C; Williamson D; Kalos M; Grupp SA
Blood; 2015 May; 125(22):3501-8. PubMed ID: 25862561
[TBL] [Abstract][Full Text] [Related]
16. Ikaros and leukaemia.
Olsson L; Johansson B
Br J Haematol; 2015 May; 169(4):479-91. PubMed ID: 25753742
[TBL] [Abstract][Full Text] [Related]
17. Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2.
Raetz EA; Cairo MS; Borowitz MJ; Lu X; Devidas M; Reid JM; Goldenberg DM; Wegener WA; Zeng H; Whitlock JA; Adamson PC; Hunger SP; Carroll WL
Pediatr Blood Cancer; 2015 Jul; 62(7):1171-5. PubMed ID: 25732247
[TBL] [Abstract][Full Text] [Related]
18. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.
Dhédin N; Huynh A; Maury S; Tabrizi R; Beldjord K; Asnafi V; Thomas X; Chevallier P; Nguyen S; Coiteux V; Bourhis JH; Hichri Y; Escoffre-Barbe M; Reman O; Graux C; Chalandon Y; Blaise D; Schanz U; Lhéritier V; Cahn JY; Dombret H; Ifrah N;
Blood; 2015 Apr; 125(16):2486-96; quiz 2586. PubMed ID: 25587040
[TBL] [Abstract][Full Text] [Related]
19. The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia.
Cheng Y; Luo Z; Yang S; Jia M; Zhao H; Xu W; Tang Y
Leuk Res; 2015 Feb; 39(2):144-50. PubMed ID: 25542697
[TBL] [Abstract][Full Text] [Related]
20. Update on biology and treatment of T-cell acute lymphoblastic leukaemia.
Patrick K; Vora A
Curr Opin Pediatr; 2015 Feb; 27(1):44-9. PubMed ID: 25502893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
